Machelle Manuel, PhD, discusses further gout treatment options to consider when target serum urate levels are not attained.
Machelle Manuel, PhD, is vice president, Medical Scientific Affairs, at Ironwood Pharmaceuticals, the manufacturer of lesinurad.
Next post in ACR 2017 Coverage
Log in to continue reading this article.
Don’t miss out on today’s top content on Rheumatology Advisor. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.